A c c e p t e d M a n u s c r i p t 2 SUMMARY: We evaluated the effects of qnrA gene on (1) survival of bacteria exposed to lethal ciprofloxacin (CIP) concentration, and (2) the development of quinolone resistance through the accumulation of amino acid substitutions in quinolone resistance-determining regions (QRDRs) of GyrA and ParC, targets of quinolones, in Escherichia coli.
SUMMARY:
We evaluated the effects of qnrA gene on (1) survival of bacteria exposed to lethal ciprofloxacin (CIP) concentration, and (2) the development of quinolone resistance through the accumulation of amino acid substitutions in quinolone resistance-determining regions (QRDRs) of GyrA and ParC, targets of quinolones, in Escherichia coli.
CIP-susceptible E. coli strains of different O-serotypes (O1, O6, O18, O25b, O74, and O78) were transformed by a recombinant plasmid harboring qnrA, and the parent strains and their transformants were subjected to killing curve assays and adaptation tests. In the killing curve assay at 2× the minimum inhibitory concentration of CIP, the viable bacterial cell numbers of strains O1, O6 and O25b were maintained at 10 We confirmed that the presence of the qnrA gene contributed to increasing bacterial survival in E. coli strains displaying certain O-serotypes. Further studies are necessary to evaluate the precise effects of the qnrA gene on quinolone resistance acquisition in Enterobacteriaceae.
A c c e p t e d M a n u s c r i p t

INTRODUCTION
Multidrug resistance in Enterobacteriaceae, including resistance to fluoroquinolones (FQs), is on the rise worldwide and has become a serious clinical concern (1-3). FQ resistance most commonly occurs as a result of mutation accumulation in the quinolone resistance-determining regions (QRDRs) of target molecules of FQs, DNA gyrase and/or topoisomerase IV (4) . In addition, plasmid-mediated quinolone resistance (PMQR) genes, including qnr, aac (6' )-Ib-cr, qepA, and oqxAB, have been recently reported as transmissible resistance mechanisms (5) (6) (7) (8) . The presence of these PMQR genes alone has been reported to elevate the minimum inhibitory concentrations (MICs) of FQs by 4-to 128-fold, although the final MIC values usually remain below the breakpoint of ciprofloxacin (CIP) for "susceptible" (≤1 μg/mL) settled by the Clinical and Laboratory Standards Institute (CLSI) (9) and that (≤0.5 μg/mL) of the European Committee on Antimicrobial Susceptibility Testing (10).
Qnr proteins belong to the pentapeptide-repeat family and protect bacteria from the binding of FQs to DNA gyrase and/or topoisomerase IV. To date, six groups of Qnr proteins have been identified (QnrA, QnrB, QnrC, QnrD, QnrS, and QnrVC) (11, 12) . Allou et al. evaluated the impact of the acquisition of genes encoding Qnrs, and found that the low-level resistance to FQs conferred by these genes was associated with decreased bactericidal activity of CIP (13) . In a preliminary study, we also found that the qnrA gene contributed to increased bacterial survival at lethal CIP concentrations. However, the precise effects of the acquisition of qnr genes on the reduced bactericidal activity of FQs and on the development of high-level quinolone resistance are not well known. Therefore, the aim of this study was to evaluate the A c c e p t e d M a n u s c r i p t effects of qnrA gene on survival of bacteria exposed to lethal CIP concentrations using Escherichia coli strains displaying various O-serotypes. In addition, the effects of acquisition of qnrA gene on the development of quinolone resistance through accumulation of amino acid substitutions in QRDRs of GyrA and ParC were also evaluated.
MATERIALS AND METHODS
Bacterial strains: A total of 12 FQ-susceptible E. coli strains of six different serotypes (O1, O6, O18, O25, O74, and O78; two strains each) were used in this study. Serotypes O1, O6, O18, and O25 are frequently detected in E. coli isolates obtained from patients with urinary tract infections (14) (15) (16) . Strains O74 and O78 were frequent serotypes detected among E. coli isolates obtained from stool specimens of 2563 healthy adult volunteers of our investigation performed at a Public Health Center in 2010. For the two strains determined as serotype O25 using E. coli antisera, genetic serotyping was also performed (17) , and both strains were identified as O25b. In addition, for all strains, multilocus sequence typing was performed by analyzing seven housekeeping genes, according to the protocol of the E. coli website (http://mlst.ucc.ie/mlst/dbs/Ecoli). Sequence types were compared with the species' population structure using eBurst (http://eburst.mlst.net/). Cloning of qnrA gene was performed using the positive strain E. coli E15, and quality control for susceptibility testing was performed using the reference strain E. coli ATCC 25922.
Cloning of the qnrA gene: QnrA gene and its surrounding regions were amplified with the A c c e p t e d M a n u s c r i p t specific primers ORF513-QnrA.f (5′-CCGGAATTCCGGCGAAGATGACTATGGCAAGC AA-3′) and ampR-QnrA.r (5′-CCCGGATCCGGGGCAGCAGGGTAAAGCGGTGAAT-3′).
The product was digested with EcoRI and BamHI (Takara Bio Inc.; Tokyo, Japan), and the resultant fragments were ligated into a cloning vector, pSTV28, which contained a reconstructed chloramphenicol-resistant gene composed of the Tn9 and β-galactosidase genes (TaKaRa). E. coli strains displaying various O-serotypes were transformed with the recombinant plasmid pSTVqnrA by electroporation, and the transformants were selected on X-gal agar containing 20 μg/mL of chloramphenicol (Sigma-Aldrich Co., LLC.; Tokyo, Japan). In addition, the cloning vector pSTV28 was introduced into each E. coli strain, and the resultant transformants were used as the parent strain of each transformant harboring qnrA gene.
Antimicrobial susceptibility test:
The MIC of CIP was determined using Etest (SYSMEX bioMérieux, Co., Ltd.; Tokyo, Japan) performed on Mueller-Hinton agar plates (Becton Dickinson Diagnostic System; Sparks, MD, USA), according to the manufacturer's procedure guidelines. The susceptibility category was determined according to CLSI criteria (9) .
Minimum bactericidal concentration (MBC) and mutant prevention concentration (MPC):
MBCs of CIP for the parent strains and transformants were determined according to the protocol recommended by the CLSI (18) . In the present study, MBCs for each strain were determined using seven different CIP concentrations (1× MIC, 1.5× MIC, 2× MIC, 2.5× MIC, A c c e p t e d M a n u s c r i p t 3× MIC, 3.5× MIC, and 4× MIC). The MBC was defined as the lowest antibiotic concentration that produced a ≥99.9% decrease in survival (in CFU/mL) relative to that of the starting inoculum.
MPCs of CIP for the parent strains and transformants were also determined, as described previously (19) . MPCs for each strain were determined using 10 different concentrations (step range for the parent strains: 0.024, 0.032, 0.047, 0.064, 0.094, 0.19, 0.25, 0.5, 0.75, and 1 μg/mL; step range for transformants: 0.38, 0.5, 0.75, 1, 1.5, 2, 3, 4, 6, and 8 μg/mL). The MPC was defined as the lowest antibiotic concentration at which no colonies grew on a plate, and the mean MPC for each strain was determined in three independent experiments that were repeated three times on different days. In addition, DNA sequences of the QRDRs of the gyrA and parC genes were performed as described previously (20) . DNA sequences were MIC culture (50 μL) was incubated on LB agar plates containing the same concentration of CIP for 24 h at 37°C. Ten colonies grown on each agar plate were randomly selected, and the MICs of CIP were determined using Etest. Of the colonies selected, one colony showing the highest MIC value was named passage 1 (P1) and subjected to the next passage. This procedure was repeated 19 times after the selection of P1.
In addition, DNA sequences of the QRDRs of the gyrA and parC genes were determined as described previously (20) . The nucleotide and deduced amino acid sequences were A c c e p t e d M a n u s c r i p t analyzed with the BLAST program (http://www.ncbi.nlm.nih.gov/blast).
RESULTS AND DISCUSSION
Among 12 FQ-susceptible E. coli strains, seven strains were identified as ST95, and two strains were identified as O25b-ST131. Acquisition of qnrA gene increased the MICs of CIP by 20.8 to 31.7 times (Table 1 ), but the MICs remained below the susceptibility breakpoint to CIP according to CLSI criteria (≤1 μg/mL). Acquisition of the qnrA gene also increased the MBC and MPC values of CIP by 15.8-to 79.1-fold (0.285-1.14 μg/mL) and by 2.6-to 21.1-fold (0.5-4 μg/mL), respectively, relative to those of the parent strains (Table 1) . These results were consistent with previous reports (21, 22) . The MBCs and MPCs of CIP for the transformants of O25b strains were highest among the O-serotypes compared, at 0.75-1.14 μg/mL and 3-4 μg/mL, respectively. These results suggested that the acquisition of the qnrA gene confers good survivability of the bacteria in the presence of FQs, indicating that O25b strains harboring qnrA gene might easily acquire resistance to FQs.
Killing curve assays showed a selective advantage for survival in the transformants harboring qnrA gene. Following exposure to 2× MIC of CIP, the parent strains showed a 10 5 -fold reduction in survival after incubation for 24 h, and no viable bacteria were recovered after 48 h (Fig. 1A) . The transformants of strains O1, O6, and O25b maintained levels of 10 5 to 10 8 CFU/mL viable bacteria after incubation for 24 h at 2× MIC of CIP, while the remaining transformants (O18, O74, and O78) showed a 10 5 -fold reduction after 24 h and no viable bacteria were recovered after incubation for 48 h (Fig. 1B) . In addition, at 3× MIC of A c c e p t e d M a n u s c r i p t CIP, only viable bacteria cells of the transformants of O25b strains were recovered up to 10 5 CFU/mL after incubation for 48 h (Fig. 2) , and the effect of qnrA gene on bacterial survival was greatest in O25b:H4-ST131 strains. These results suggested that the contribution of qnrA gene to bacterial survival is not equivalent in all serotypes of E. coli strains. To date, some investigators have reported that E. coli isolates with qnr genes could survive longer than isolates without qnr genes in the presence of CIP (13, 21) . In the present study, we also confirmed that the acquisition of qnrA gene contributed to increased bacterial survival under exposure to lethal CIP concentrations in E. coli strains displaying certain O-serotypes (O1, O6, and O25b). Therefore, the presence of qnr genes might well confer an appreciable effect on bacterial viability under conditions of lethal CIP concentration. (Table 1 and Table 3 ). This suggests that QnrA might completely protect DNA gyrase and/or topoisomerase IV from CIP; therefore, the transformants harboring qnrA In conclusion, we confirmed that the acquisition of qnrA gene alone contributed to increased survival of E. coli exposed to lethal CIP concentration, but did not necessarily accelerate the accumulation of amino acid substitutions in QRDR mutations. The effects of qnrA gene on viability were greatest in O25b strains exposed to a lethal amount of CIP among all O-serotypes compared, which could explain the rapid spread of E. coli O25b:H4-ST131.
At present, the qnr genes are rapidly spreading among the family Enterobacteriaceae. A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t 
